1. Home
  2. |Insights
  3. |Evolving ESG Standards: Disclosures, Procurement, Insurer Demands, and Beyond

Evolving ESG Standards: Disclosures, Procurement, Insurer Demands, and Beyond

Webinar | 11.16.21, 7:00 AM EST - 8:00 AM EST

Environmental, Social, and Governance (ESG) considerations are being elevated in corporate, corporate stakeholder, and regulator discourse as never before. Many companies are experiencing ESG pressures for the first time, and indeed they may seem new to entire industries. However, ESG has become an essential institutional investor criteria and will increasingly need to be integrated into the supply and value chains of public and private corporations as financial and other regulators catch up.


Similarly, the Biden Administration has been unabashedly vocal about the need for companies to disclose ESG performance, and to ensure that disclosures made are accurate with respect to ESG criteria. These demands appear to apply whether companies are directly regulated by the federal government, are vendors to the government, or otherwise—but the regulations behind the platitudes are still forthcoming. Investors, insurers, and other stakeholders, meanwhile, are not waiting for the government and instead are seeking objective, credible metrics of a company’s ESG performance, from carbon-footprint reduction, to pay equity, to supply-chain transparency.


During this webinar, Crowell & Moring attorneys will walk you through how plans and convictions become actions and begin to have real world impact.


For more information, please visit these areas: Environmental, Social, and Governance, Environment and Natural Resources, Government Contracts , White Collar and Regulatory Enforcement

Participants

Insights

Webinar | 12.10.26

The Third-Party Perspective: Protecting Payors’ Interests in Antitrust Investigations

The Trump administration has sharpened its focus on hospital systems as a key driver of rising health care costs, and the DOJ and FTC are actively patrolling for anticompetitive conduct and mergers that contribute to these rising costs. Managed care organizations are a critical source of evidence in these investigations and are likely to receive Civil Investigative Demands (CIDs), be contacted by agency staff, or may consider proactively engaging with antitrust authorities to address competitive concerns in their markets.